Free Trial

UroGen Pharma (URGN) Earnings Date, Estimates & Call Transcripts

$16.23
+0.44 (+2.79%)
(As of 03:39 PM ET)

Earnings Summary

Upcoming
Earnings Date
Aug. 8Estimated
Actual EPS
(May. 13)
-$0.97 Missed By -$0.04
Consensus EPS
(May. 13)
-$0.93
Skip Charts & View Estimated and Actual Earnings Data

URGN Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

URGN Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

UroGen Pharma Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20241($0.94)($0.94)($0.94)
Q2 20241($0.77)($0.77)($0.77)
Q3 20241($0.75)($0.75)($0.75)
Q4 20241($0.71)($0.71)($0.71)
FY 20244($3.17)($3.17)($3.17)
Q1 20251($0.75)($0.75)($0.75)
Q2 20251($0.78)($0.78)($0.78)
Q3 20251($0.61)($0.61)($0.61)
Q4 20251($0.59)($0.59)($0.59)
FY 20254($2.73)($2.73)($2.73)

URGN Earnings Date and Information

UroGen Pharma last announced its quarterly earnings data on May 13th, 2024. The reported ($0.97) earnings per share for the quarter, missing the consensus estimate of ($0.93) by $0.04. The company earned $18.78 million during the quarter, compared to the consensus estimate of $20.73 million. UroGen Pharma has generated ($3.40) earnings per share over the last year (($3.40) diluted earnings per share). Earnings for UroGen Pharma are expected to grow in the coming year, from ($3.52) to ($2.52) per share. UroGen Pharma has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 8th, 2024 based off prior year's report dates.

UroGen Pharma Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/8/2024
(Estimated)
------- 
5/13/2024Q1 2024($0.93)($0.97)($0.04)($0.97)$20.73 million$18.78 million
3/14/2024Q4 2023($0.67)($0.72)($0.05)($0.72)$22.30 million$23.53 million    
11/14/2023Q3 2023($0.89)($0.68)+$0.21($0.68)$19.80 million$20.85 million
8/10/2023Q2 2023($1.13)($1.03)+$0.10($1.03)$19.90 million$21.14 million
5/11/2023Q1 2023($1.39)($1.30)+$0.09($1.30)$16.55 million$17.19 million
3/16/2023Q4 2022($1.12)($1.22)($0.10)($1.22)$18.25 million$18.09 million
11/10/2022Q3 2022($1.22)($1.13)+$0.09($1.13)$20.30 million$16.10 million    
8/11/2022Q2 2022($1.33)($1.18)+$0.15($1.18)$16.95 million$16.60 million
5/10/2022Q1 2022($1.36)($1.25)+$0.11($1.25)$15.62 million$13.56 million
3/21/2022Q4 2021($1.18)($1.27)($0.09)($1.27)$16.15 million$16.17 million    
11/15/2021Q3 2021($1.26)($1.35)($0.09)($1.35)$15.90 million$11.35 million    
8/4/2021Q2 2021($1.10)($1.17)($0.07)($1.17)$13.00 million$13.03 million    
5/13/2021Q1 2021($1.26)($1.17)+$0.09($1.17)$8.41 million$7.49 million  
3/17/2021Q4 2020($1.37)($1.38)($0.01)($1.38)$7.21 million$7.97 million  
11/9/2020Q3 2020($1.47)($1.31)+$0.16($1.31)$3.21 million$3.46 million  
8/10/2020Q2 2020($1.59)($1.44)+$0.15($1.44)$0.50 million$0.37 million  
5/7/2020Q1 2020($1.62)($1.79)($0.17)($1.79)--  
3/2/2020Q4 2019($1.70)($1.86)($0.16)($1.86)--  
11/12/2019Q3($1.26)($1.06)+$0.20($1.06)--  
8/9/2019Q2 2019($1.20)($1.08)+$0.12($1.08)-$0.02 million  

UroGen Pharma Earnings - Frequently Asked Questions

When is UroGen Pharma's earnings date?

UroGen Pharma has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 8th, 2024 based off last year's report dates. Learn more on URGN's earnings history.

Did UroGen Pharma beat their earnings estimates last quarter?

In the previous quarter, UroGen Pharma (NASDAQ:URGN) missed the analysts' consensus estimate of ($0.93) by $0.04 with a reported earnings per share (EPS) of ($0.97). Learn more on analysts' earnings estimate vs. URGN's actual earnings.

How much revenue does UroGen Pharma generate each year?

UroGen Pharma (NASDAQ:URGN) has a recorded annual revenue of $82.71 million.

How much profit does UroGen Pharma generate each year?

UroGen Pharma (NASDAQ:URGN) has a recorded net income of -$102.24 million. URGN has generated -$3.40 earnings per share over the last four quarters.

What is UroGen Pharma's EPS forecast for next year?

UroGen Pharma's earnings are expected to grow from ($3.52) per share to ($2.52) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:URGN) was last updated on 7/22/2024 by MarketBeat.com Staff

From Our Partners